Company Filing History:
Years Active: 2006-2009
Title: Glenn Friedman: Innovator in Cancer Treatment
Introduction
Glenn Friedman is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds.
Latest Patents
Friedman holds 3 patents related to methods for treating or preventing metastatic cancer using benzopyranone compounds. His inventions focus on the use of benzopyranone compounds and compositions that can effectively treat or prevent cancer. These compounds are designed to inhibit the growth of cancer cells or neoplastic cells by administering an effective amount of the benzopyranone compound. The compounds have specific formulas that include halogen, trifluoromethyl, or alkyl groups.
Career Highlights
Glenn Friedman is associated with Signal Pharmaceuticals, Inc., where he continues to work on groundbreaking research in cancer therapies. His dedication to innovation in this field has positioned him as a key figure in the development of new treatment methods.
Collaborations
Friedman collaborates with notable colleagues, including Jeffrey A McKie and Jonathan Wright, who contribute to his research efforts and advancements in cancer treatment.
Conclusion
Glenn Friedman is a prominent inventor whose work in developing benzopyranone compounds has the potential to revolutionize cancer treatment. His contributions to the field are invaluable and continue to inspire further research and innovation.